Company
Panome Bio
Multi-Omics Services for Comprehensive Biomarker Analysis
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Customers
- life science community
- panomebio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Through leading-edge Metabolomics, Proteomics, and Multi-Omics Integration technologies, Panome Bio accelerates innovation within the life science community. We are committed to delivering unparalleled discovery potential, data quality, transparency, and customer experience, as our customers drive groundbreaking advancements in biotechnology, and we together create a healthier future.
Funding snapshot
- Total raised
- $12MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $6M2024-11-14
Funding rounds
- Round, 2024
- $6M2024-11-14, SEC form D sold, 6 investors
- Round, 2023
- $6M2023-02-15, SEC form D sold, 6 investors
Products
- Other
- Integrated Multi-omics
- Other
- Next-Generation Metabolomics
- Other
- Panome Proteomics
Loading relationship preview